UNC10142
UNC10142 (Compound 44) is a first-in-class small molecule antagonist of CHD1 that binds with an IC50 value of 1.7 μM. UNC10142 leads to a dose-dependent reduction in viability in PTEN-deficient prostate cancer cells[1].
Product Specifications
UNSPSC
12352005
Target
Epigenetic Reader Domain
Type
Reference compound
Related Pathways
Epigenetics
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/unc10142.html
Concentration
10mM
Purity
99.74
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
COC1=C(OCCCN2CCCCC2)C=C(N=C(N3CCCCCCCC3)N=C4N(C)C5CCN(C(C)=O)CC5)C4=C1
Molecular Formula
C33H52N6O3
Molecular Weight
580.80
References & Citations
[1]Johnson RL, et al. Discovery of CHD1 Antagonists for PTEN-Deficient Prostate Cancer. J Med Chem. 2024 Nov 28;67 (22) :20056-20075.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
Phase 2
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1341617-01 0.02 mg (E-Coli)
Recombinant Xenopus laevis S-phase kinase-associated protein 1 (skp1)
Sign In for Pricing
View Details MBS1341617-02 0.1 mg (E-Coli)
Recombinant Xenopus laevis S-phase kinase-associated protein 1 (skp1)
Sign In for Pricing
View Details 
MBS1341617-03 0.02 mg (Yeast)
Recombinant Xenopus laevis S-phase kinase-associated protein 1 (skp1)
Sign In for Pricing
View Details 
MBS1341617-04 0.1 mg (Yeast)
Recombinant Xenopus laevis S-phase kinase-associated protein 1 (skp1)
Sign In for Pricing
View Details MBS1341617-05 0.02 mg (Baculovirus)
Recombinant Xenopus laevis S-phase kinase-associated protein 1 (skp1)
Sign In for Pricing
View Details